iNtRON Biotechnology, Inc. – Trademark Portfolio
Entity Type: 03
iNtRON Biotechnology, Inc. owns a portfolio of 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ITLYSIN, PHAGERIA, PHAGERUS, IM-MUCODR, and PHAGERIARUS. Of these, 6 are registered. The portfolio spans 3 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 1 (Chemicals). Headquartered in Sungnam-Si, Kyungki-Do.
#701~704 Jungang-Induspia
138-6 Sangdaewon-Dong, Joongwon-Ku
Sungnam-Si, Kyungki-Do 462-120 , KR
Showing of trademarks Trademarks
Trademark Classifications
iNtRON Biotechnology, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does iNtRON Biotechnology, Inc. have?
iNtRON Biotechnology, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 2 cancelled.
What trademark classes does iNtRON Biotechnology, Inc. file in?
iNtRON Biotechnology, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are iNtRON Biotechnology, Inc.'s most well-known trademarks?
iNtRON Biotechnology, Inc.'s registered trademark portfolio includes well-known marks such as ITLYSIN, PHAGERIA, PHAGERUS, IM-MUCODR, and PHAGERIARUS. These are among 6 currently registered trademarks in the portfolio.
What is iNtRON Biotechnology, Inc.'s trademark registration success rate?
iNtRON Biotechnology, Inc. has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.